J. Leigh  Leasure

Prof. J. Leigh Leasure


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Neuropharmacology
Verified
Journal Article
Closed access
TSTimothy Schallert
Timothy Schallert
SFSheila M Fleming
Sheila M Fleming
JLJ. Leigh Leasure
J. Leigh Leasure
JTJennifer L Tillerson
Jennifer L Tillerson
SBSondra T. Bland
Sondra T. Bland

1 October 2008 in Neuroscience
Verified
Journal Article
Closed access
JLJ. Leigh Leasure
J. Leigh Leasure
MJM. Jones
M. Jones

1 February 1998 in Brain Research
Verified
Journal Article
Closed access
JLJ. Leigh Leasure
J. Leigh Leasure
DKDorothy A Kozlowski
Dorothy A Kozlowski
DJDebra C James
Debra C James
JGJeffrey E Gotts
Jeffrey E Gotts
TSTimothy Schallert
Timothy Schallert

2 November 2015 in Frontiers in Psychiatry
Verified
Journal Article
Open access
JLJ. Leigh Leasure
J. Leigh Leasure
CNClayton Neighbors
Clayton Neighbors
CHCraig E. Henderson
Craig E. Henderson
CYChelsie M. Young
Chelsie M. Young
Exercise provides a wealth of benefits to brain and body, and is regarded as a protective factor against disease. Protective factors tend to cluster together - that is, people who engage in one healthy behavior, such as exercise, also engage in other healthy behaviors, such as maintaining a nutritious diet and getting sufficient sleep. In contrast to exercise, alcohol consumption is not typically regarded as a health-promoting behavior, although moderate intake has been associated with a lower risk of cardiovascular disease. Surprisingly, several large, population-based studies have shown a positive association between physical activity and alcohol intake. The present review focuses on what is known about this relationship, including potential neural bases as well as moderating factors, and discusses important directions for further study, such as a more thorough characterization of people who both drink and exercise. We focus on ramifications for intervening with people that have alcohol use disorders (AUD), as exercise has been assessed as both a treatment and preventive measure, with mixed results. We believe that, in order for such interventions to be effective, clinical trials must distinguish treatment-seeking populations from non, as well as ensure that the use of exercise as a tool to decrease alcohol consumption is made explicit. We posit that a better understanding of the relationship between physical activity and alcohol intake will maximize intervention efforts by informing the design of clinical trials and research-driven prevention strategies, as well as enable individuals to make educated decisions about their health behaviors.

1 March 2008 in Environmental Health Perspectives
Verified
Journal Article
Open access
JLJ. Leigh Leasure
J. Leigh Leasure
AGAnand Giddabasappa
Anand Giddabasappa
SCShawntay Chaney
Shawntay Chaney
JJJerry E. Johnson
Jerry E. Johnson
KPKonstantinos Pothakos
Konstantinos Pothakos
DFDonald A. Fox
Donald A. Fox
Background: Low-level developmental lead exposure is linked to cognitive and neurological disorders in children. However, the long-term effects of gestational lead exposure (GLE) have received little attention. Objectives: Our goals were to establish a murine model of human equivalent GLE and to determine dose–response effects on body weight, motor functions, and dopamine neurochemistry in year-old offspring. Methods: We exposed female C57BL/6 mice to water containing 0, 27 (low), 55 (moderate), or 109 ppm (high) of lead from 2 weeks prior to mating, throughout gestation, and until postnatal day 10 (PN10). Maternal and litter measures, blood lead concentrations ([BPb]), and body weights were obtained throughout the experiment. Locomotor behavior in the absence and presence of amphetamine, running wheel activity, rotarod test, and dopamine utilization were examined in year-old mice. Results: Peak [BPb] were < 1, ≤ 10, 24–27, and 33–42 μg/dL in control, low-, moderate- and high-dose GLE groups at PN0–10, respectively. Year-old male but not female GLE mice exhibited late-onset obesity. Similarly, we observed male-specific decreased spontaneous motor activity, increased amphetamine-induced motor activity, and decreased rotarod performance in year-old GLE mice. Levels of dopamine and its major metabolite were altered in year-old male mice, although only forebrain utilization increased. GLE-induced alterations were consistently larger in low-dose GLE mice. Conclusions: Our novel results show that GLE produced permanent male-specific deficits. The nonmonotonic dose-dependent responses showed that low-level GLE produced the most adverse effects. These data reinforce the idea that lifetime measures of dose–response toxicant exposure should be a component of the neurotoxic risk assessment process.

1 November 2000 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
TSTimothy Schallert
Timothy Schallert
JLJ. Leigh Leasure
J. Leigh Leasure
BKBryan Kolb
Bryan Kolb
Considerable structural plasticity is possible in the damaged neocortex and connected brain areas, and the potential for significant functional recovery remains even during the chronic phases of the recovery process. In this article, the authors review the literature on use-dependent morphologic events, focusing on the direct interaction of behavioral experience and structural changes associated with plasticity and degeneration. Experience-associated neural changes have the potential to either hinder or enhance functional recovery; therefore, issues concerning the nature, timing, and intensity of behavior-based intervention strategies are addressed.